Inside the ICE House
Inceptive CEO Jakob Uszkoreit on Designing Medicines That Work Like Life Itself
21m
Inceptive CEO Jakob Uszkoreit goes Inside the ICE House to challenge the foundational assumptions of modern drug discovery, arguing that AI will enable medicines that work with the body's natural complexity rather than against it. He discusses Inceptive's partnership with Alnylam Pharmaceuticals and why their RNA interference platform and rich data history make them a uniquely powerful AI collaborator. Uszkoreit explains why partnerships are essential for a small company with broadly applicable technology, and why the long-term prize is therapies that are gentler, earlier, and truly personalized.
Up Next in 2026 | Inside the ICE House
-
Formation Bio CEO Ben Liu on Fixing t...
Formation Bio is rewriting the rules of drug development at a time when AI is accelerating drug discovery far faster than the industry can bring new therapies to patients. CEO Ben Liu goes Inside the ICE House to explain why the real bottleneck in pharma isn't finding promising drug candidates, i...
-
Third Coast Bank CEO Bart Caraway on ...
Third Coast Bancshares Founder and CEO Bart Caraway joins Inside the ICE House to discuss building a Texas-based community bank from a vision into a publicly traded company now listed on the New York Stock Exchange. He reflects on launching the bank in 2008 at the onset of the Great Recession and...
-
NYSE Texas: FOA's Michael Fant on Rev...
Finance of America SVP of Finance Michael Fant joins Inside the ICE House to discuss how the company has grown into the largest originator and servicer of reverse mortgages in the United States, helping seniors tap into their home equity to fund retirement. He shares how Finance of America has sh...
